Experts hail highly successful trial of Lilly's cholesterol-busting drug lepodisiran

Experts hail highly successful trial of Lilly's cholesterol-busting drug lepodisiran

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that inhibits the body's production of a dangerous type of "bad" cholesterol."

Millions Share a Deadly Genetic Heart Risk. This Experimental Drug Could Be a Game Changer

About one in five Americans has a genetic risk for a dangerous type of cholesterol.

A single dose of an experimental medicine drastically reduced the levels of a deadly type of cholesterol, often considered intractable, for up to a year. Lipoprotein (a) is a type of cholesterol lurking in the body, not detected by routine tests and imperturbable by existing medications, diet or exercise. The finding, say cardiologists, is a critical step towards the treatment of millions of genetically predisposed Americans at abnormally high l…

Experimental Drug Shows Promise In Eliminating Hard-To-Treat Deadly Cholesterol

A single dose of lepodisiran dramatically lowered dangerous lipoprotein(a) levels for up to a year, offering new hope for heart disease treatment.